Jae-Wook Oh

Narciclasine Exerts Anticancer Activity in Colorectal Cancer Cells in Association with HELLS Downregulation and DNA Damage-Associated Responses

Narciclasine is a promising natural-product-derived lead compound for further preclinical evaluation in HELLS-associated CRC vulnerabilities and is associated with HELLS downregulation, DNA damage-associated signaling, and apoptosis in CRC cells.